What Do Current Information and Evidence Suggest to Us for Oxytocin Use During Caesarean Section?
TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, cilt.43, sa.2, ss.113-115, 2015 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 43 Sayı: 2
- Basım Tarihi: 2015
- Doi Numarası: 10.5152/tjar.2014.76753
- Dergi Adı: TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.113-115
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Gazi Üniversitesi Adresli: Evet
Özet
Oxytocin is the first-line agent in the prevention and treatment of uterine atony and maintenance of uterine tone. Since there are several different practices related to the use of oxytocin during caesarean sections, we would like to address the latest information and evidence for rational oxytocin use.